Connect with us

Culture

SXSW Wants You To Vote On Marijuana And Psychedelics Panels For 2021 Event

Published

on

Dozens of marijuana-related panels have been proposed for next year’s South by Southwest (SXSW) event, and several other submissions mention psychedelics. Now the festival needs the public’s help in deciding which ones make the cut.

Through Friday, SXSW is asking people to comment and vote on 48 proposed panels for SXSW 2021 that involve cannabis and four that mention psychedelics. The festival, normally a trendy annual event in Austin, will be held online in March.

Proposals for the panels span the gamut, from issues of social equity in legal cannabis to DIY healthcare and home entheogenic medicines. Most of the proposals have an industry feel—a nod to the festival’s “cannabusiness” track featured in recent years—while other pitches are especially timely: More than one mentions cannabis and COVID-19.

Anyone is free to comment on the proposals through the festival’s PanelPicker tool. To vote, you’ll need to sign up for a free SXSW account.

Among some of the notable names put forward for the 2021 festival include Bay Area recording artist and entrepreneur Berner, co-founder of the marijuana brand Cookies; Cat Packer, director of the Los Angeles Department of Cannabis Regulation; Al Harrington, a former NBA player who founded his own cannabis company; and Toi Hutchison, senior advisor on cannabis control to Illinois Gov. J.B. Pritzker (D).

There’s a lot of overlap between panel topics, so be sure to look through them all. Try searching with terms like “cannabis” or “psychedelics.” Many carry the festival’s “cannabusiness” tag.

Here’s just a taste of some of the options that could be featured at SXSW 2021:

Celebrities Redefining Cannabis Entrepreneurship — It wouldn’t be SXSW without celebrity. This panel features Gilbert Anthony Miliam Jr., the musical artist better known as Berner, who co-founded and runs the trendsetting cannabis brand Cookies. The panel centers on how entrepreneurs of color in the marijuana space are working to rectify past injustices of the drug war and what the future intersection of entertainment and cannabis might look like.

The Future of Cannabis Is Appellation Designation — Interested in craft cannabis? Representatives from Big Rock Partners, Sonoma Hills Farm, Henry’s Original and Moonmade Farms discuss how a new California “appellation of origin” law could impact growers and help inform consumers about where their cannabis comes from.

The Stoners and the Suits: Building Bridges — One of the earliest entrepreneurs to enter legal cannabis, Andrew DeAngelo, president of DeAngelo Brothers Productions LLC, shares how he’s been “both a ‘stoner’ and a ‘suit'” during his 35 years in the marijuana business and offers ideas about how to build trust between groups that often find themselves at odds.

DIY Healthcare: From Seed to Self Reliance — For those who like to get their hands dirty, Amanda Reiman, CEO and founder of Personal Plants, explains home production and processing of plant-based medicine, including cannabis and psychedelics.

Can We Ensure Equity In Cannabis Policy? #YesWeCan — This solo panel by Cat Packer, director of the Los Angeles Department of Cannabis Regulation, focuses on how we can “build a more equitable society for those previously and currently affected by cannabis policy,” as well as other areas of society affected by cannabis policy. Packer, who previously worked for the advocacy group the Drug Policy Alliance, shares her perspective as a self-described “agitator” within the space and acknowledges there’s still work to be done.

The Crop They Won’t Share–Disrupting Legalization — “Legal Cannabis Doesn’t Care About Black People,” begins the description of this panel, which notes that 96 percent of cannabis business licenses in the U.S. have gone to white owners. Featuring speakers such as Toi Hutchison, senior advisor on cannabis control to Illinois Gov. J.B. Pritzker (D), and Melek Dexter, founder and CEO of Lets ReUP and Do Better Project, this is yet another worthy look at the need for social justice in the cannabis industry.

The Urgency for An Equitable Cannabis Industry — Another proposed panel centering on the need for social equity in cannabis, this one features a more industry-side perspective. It includes Tahir Johnson, business development and diversity and inclusion manager at the National Cannabis Industry Association, as well as Curaleaf VP of Social Responsibility Khadija Tribble and representatives from Lantern and Fyllo.

Psychedelics: Rewiring Mental Health Care — Professors from Johns Hopkins University and the Mount Sinai School of Medicine are among the speakers on this panel looking into the therapeutic uses of psilocybin, the main psychoactive ingredient in psychedelic mushrooms. Panelists will explain psilocybin’s potential benefits to treat psychiatric and behavioral disorders, discuss common misconceptions and examine existing problems in mental health care.

Reporting on the Corporatization of Psychedelics — With more and more interest in the mental health applications of psychedelics, yet another illicit drug market could soon go legal. In this panel, the CEO and managing editor of DoubleBlind Mag, which covers psychedelics, sit down to discuss how cannabis paved the way for psychedelics and how for-profit interests could upset efforts at equity.

It’s not yet clear how many of the proposals will be selected. In 2019, the festival boasted more than 20 cannabis events, including discussions on entrepreneurship by women and the prospect of marijuana reform in Texas. Sixty-two cannabis proposals were submitted for consideration in that festival.

SXSX’s 2019 cannabis track also caused some controversy when former House Speaker John Boehner (R), who joined the board of a major cannabis firm after leaving office, delivered a keynote address, which drew protests from social justice advocates who argued that corporate marijuana firms had overlooked equity issues.

SXSW 2020 was scheduled to feature 24 different cannabis panels, but the festival was canceled due to the pandemic.

Texas Democrats Say Marijuana Can Help The Economy, But Republicans May Stand In The Way

Photo courtesy of Philip Steffan

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.

Ben Adlin is a Seattle-based writer and editor. He has covered cannabis as a journalist since 2011, most recently as a senior news editor for Leafly.

Culture

SXSW Selects Multiple Marijuana And Psychedelics Panels For 2022 Festival

Published

on

People who attend the 2022 South By Southwest (SXSW) festival will have the chance to hear from a range of experts and stakeholders on marijuana and psychedelics issues.

A number of drug policy panels have been selected for the event, which runs from March 11-20. While cannabis has been a consistent track at SXSW in recent years, psychedelics is getting a lot more attention as the reform movement continues to expand.

The public played a role in shaping the agenda, voting on nearly 100 proposed panels on drug-related topics earlier this year. Now SXSW has narrowed it down, choosing nine marijuana panels and seven dealing with psychedelics.

When voting started, there were about five times as many proposed psychedelics panels for 2022 compared to those proposed for the 2021 event. There’s also a stronger emphasis on social equity-themed panels for cannabis, reflecting the evolving conversation around reform.

While there aren’t specific “tracks” for cannabis panels this year as was the case for past events, there are designated marijuana and psychedelics “summits.”

One is called the “Cannabis Industry Evolution.” Here’s the description

“As the cannabis legalization movement continues to gain momentum across the globe, so does the immense opportunity for entrepreneurs, plus new and established businesses. The Cannabis Industry Evolution Summit explores today’s successful companies, along with ideas and products that will push the industry forward over the coming years.”

The other is titled “The State of Psychedelics.” Here’s that description: 

“Psychedelics have played a role in human culture for centuries in both spiritual and recreational settings, and recent breakthrough research of psychedelics as a treatment for a wide range of psychiatric conditions shows promise. The Psychedelics Summit aims to explore the medical, economic, and ethical implications of these tripped-out chemicals.”

Here’s an overview of some of the notable marijuana and psychedelics panels that will be featured at the 2022 SXSW: 

Marijuana

Sue ‘N The DEA: Breaking The 50-Year NIDA Monopoly

Sue Sisley of the Scottsdale Research Institute has played a key role in pushing the Drug Enforcement Administration to expand the number of federally authorized marijuana manufacturers and break the current monopoly. She’ll be joined by Matt Zorn and Shane Pennington, attorneys who have worked with Sisley on a number of lawsuits to force a policy change, for a conversation on the need to remove cannabis from its Schedule I status to promote research into the plant.

Cannabis vs. the Opioid Crisis?

Ricardo Baca, a journalist who started the cannabis-focused PR firm Grasslands, will host a chat on the science of whether cannabis can serve as an alternative to opioids amid an overdose crisis and whether people could use marijuana to help overcome opioid addictions.

Puff, Puff, Pass The Rewards: Equity In Cannabis Legalization

Leafly’s Janessa Bailey will talk about equity as more states move to legalize marijuana. The focus of this event is on understanding the context of the war on drugs and how discriminatory policies have alienated certain communities from benefiting from the legalization movement. It would look at possible solutions to the issue at the state level.

“As the fastest-growing American industry, cannabis has offered new economic opportunities to people across the country, but for many, those opportunities are still out of reach,” a description states. “As more states legalize, crafting policies that help to create a fair and equitable cannabis industry has never been more important.”

Cannabis: the Next Frontier in CPG

Representatives of major cannabis companies such a Curaleaf, Trulieve and Green Thumb Industries will discuss how marijuana stands out among other consumer packaged goods and “what the future of mainstream cannabis experiences looks like, the specific barriers the industry must overcome to reach this point, and how brands can prepare for this seismic shift.”

Psychedelics

Psychedelics For Therapeutics And Well-Being

Professors from John Hopkins University and Yale University will talk about the therapeutic potential of psychedelics with Tim Ferriss, an entrepreneur who has invested significantly into the research movement.

Questions that will be raised by the panel include: “How can psychedelics be widely used to alleviate human suffering through clinician-guided treatment of illnesses such as depression, PTSD, and addiction? Do mystical-type and insightful-type experiences associated with these substances improve overall well-being in patients and in healthy individuals? How can investors make psychedelic medicine accessible by financing academic research and for-profit companies and clinics?”

The Ethics Of “Mainstreaming” Psychedelics

DoubleBlind Magazine will be leading a conversation with expects including staff from the Multidisciplinary Association for Psychedelic Studies that will touch on the “unique ethical considerations around commodifying psychedelics” and the “moral obligation of psychedelic companies to give back to Indigenous stewards of psychedelic medicines.”

“The interest in psychedelics among the general population is growing exponentially,” a description says. “Meanwhile, hundreds of millions of dollars are pouring into psychedelic drug development, with some projecting the industry is less than five years behind cannabis.”

Have A Nice Trip: The Rise of Psychedelic Tourism

This panel will look at the rise of “psychedelic retreats” that have been “glamorized, dramatized, championed, and vilified by Hollywood.”

“In this session, you’ll learn what actually happens at a psychedelic retreat—where and how they operate amidst a complex, evolving web of state and national regulations; the daily work of psychedelic retreat facilitators; and the trends converging to drive this burgeoning new category of luxury travel,” a description says.

New Marijuana Laws Take Effect Across The U.S. With The New Year

Image element courtesy of Kristie Gianopulos.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading

Culture

One-Third Of Programmers Use Marijuana While Working, With Many Touting Creative Benefits, Study Finds

Published

on

More than one-third of software programmers say they’ve used marijuana while working, with many finding that it helps promote creativity and get them into the “programming zone,” according to a new study.

Researchers at the University of Michigan said that anecdotal evidence suggested that those in programming were more likely to use cannabis on the job, so they set out to conduct the “first large-scale survey” on the topic, asking 803 developers to detail how marijuana comes into play in their work.

A main motivation for the study was the fact that drug testing policies remain common in the programming sector, which may be contributing to “hiring shortages for certain jobs.”

That’s even the case at the federal level, the study authors note, citing comments by former FBI Director James Comey, who said in 2014 that he was interested in loosening employment policies around cannabis because some prospective agents “want to smoke weed on the way to the interview.”

“This prohibition of cannabis use in software engineering has contributed to a widely-reported hiring shortage for certain US government programming jobs,” the study says.

All told, 35 percent of survey participants said that they’ve “tried cannabis while programming or completing another software engineering-related task.” Seventy-three percent of that group said they’ve consumed marijuana while working in the past year.

The study—titled “Hashing It Out: A Survey of Programmers’ Cannabis Usage, Perception, and Motivation” and published this month in Cornell University’s arXiv—also looked at frequency of use among those who said they’ve used marijuana while engineering.

Fifty-three percent said they’ve consumed cannabis while programming at least 12 times, 27 percent said they used it at least twice a week and four percent said they use it while working on a nearly daily basis.

The study authors wanted to get a better understanding of why programmers chose to consume marijuana, too. And they found that the most common tasks that people used marijuana for were brainstorming, prototyping, coding and testing.

“Overall, we found that programmers were more likely to report enjoyment or programming enhancement motivations than wellness motivations: the most common reasons were ‘to make programming-related tasks more enjoyable’ (61%) and ‘to think of more creative programming solutions’ (53%),” the study found. “In fact, all programming enhancement reasons were selected by at least 30% of respondents. On the other hand, general wellness related reasons (such as mitigating pain and anxiety) were all cited by less than 30% of respondents. Thus, while wellness does motivate some cannabis use while programming, it is not the most common motivation.”

While there’s a notable prevalence of cannabis consumption among programmers, even most of those who don’t use marijuana are supportive of reform, the study found.

“Ninety-one percent of our participants say that marijuana use should be legal for both recreational and medicinal use compared to 60 percent of the general United States population in 2021,” the authors wrote.

The study also found that “cannabis use while programming occurs at similar rates for programming employees, managers and students despite differences in cannabis perceptions and visibility.”

“Our results have implications for programming job drug policies and motivate future research into cannabis use while programming,” the study states.

Drug testing policies have become a hot topic as more states enact legalization.

After New York opted to end prohibition this year, for example, the state Department of Labor announced that most employers are no longer allowed to drug test most workers for cannabis.

Amazon recently said that its earlier decision to end drug testing for cannabis will also be retroactive, meaning former workers and applicants who were punished for testing positive for THC will have their employment eligibility restored.

Lawmakers in the Senate and House have both included language in recent appropriations reports urging a review of employment policies for federal agencies with respect to personal use of cannabis. The House version passed in July, while the Senate Democrats’ report was released in October.

The Office of Personnel Management (OPM) issued a memo to federal agencies this year that says admitting to past marijuana use should not automatically disqualify people from being employed in the federal government.

Meanwhile, the Biden administration came under criticism after it was reported that it had fired or otherwise punished dozens of staffers who admitted to prior marijuana use. That came after the White House instituted a policy of granting waivers to some staff who’ve used cannabis.

Press Secretary Jen Psaki subsequently said that nobody in the White House was fired for “marijuana usage from years ago,” nor has anyone been terminated “due to casual or infrequent use during the prior 12 months.” However, she’s consistently declined to speak to the extent to which staff have been suspended or placed in a remote work program because they were honest about their history with marijuana on a federal form that’s part of the background check process.

Researcher Uses Reddit To Learn What Kinds Of Marijuana Posts Influenced Legalization Attitudes

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading

Culture

Researcher Uses Reddit To Learn What Kinds Of Marijuana Posts Influenced Legalization Attitudes

Published

on

Social media is a powerful tool in shaping political discourse, and a recent study that examined Reddit posts spanning over a decade sheds light on exactly what kinds of conversations may have influenced the public’s shift in support of marijuana legalization.

A Brown University researcher used machine learning to analyze more than three million Reddit comments from 2009 to 2019—a key timeframe in the state-level legalization movement—to better understand the online conversations that have driven people to back reform.

A dissertation from Ph.D. candidate Babak Hemmatian—titled, “Taking the High Road: A Big Data Investigation of Natural Discourse in the Emerging U.S. Consensus about Marijuana Legalization”—revealed some surprising trends. Specifically, it seems that while sharing personal anecdotes has historically been a major factor in changing hearts and minds, people posting more generalized, character judgment-based arguments was a more clear harbinger for state-level cannabis reform.

“Marijuana legalization is a highly unusual topic in how a bipartisan consensus was reached in a matter of years while the American society was otherwise becoming more polarized,” Hemmatian told Marijuana Moment. “I wanted to know if the way the public discusses marijuana facilitated this unusual shift, and how the societal change in attitudes in turn affected how we talk about cannabis.”

Character judgements—or, “highly moralistic assertions about people’s timeless attributes” like whether being a prohibitionist makes someone a bad person—more commonly preceded state legalization efforts, particularly around 2012 as the first states moved to end prohibition, the study found.

“Anecdotes were less often used to persuade people, meaning their persuasive potential was somewhat wasted,” Hemmatian said. “Still, people did often briefly mention them to buttress more general claims like the mentioned character judgments.”

There were some other interesting themes identified in the study. For example, discussions of the health impacts of cannabis “only picked up after legalization was all but over, and only in casual conversations.” Legal implications of reform, meanwhile, “were not prominently discussed even after legalization had succeeded in most states.”

“Both topics are highly relevant to whether and how the substance should be de-regulated, but were ignored in decision-making and at best attended to once the societal decision was already made,” the study author said.

“While not the most persuasive approach according to previous research, character judgments may have still pushed people who were on the fence but not diametrically opposed to legalization over to the pro-legalization camp,” he continued. “This is because they highly simplify decision-making: One no longer needs to know the complicated effects of cannabis on health, the economy and the society to make up their mind; they just need to think through their personal moral principles. This may have been comforting during a transition period when the uncertainty surrounding marijuana’s status would have been anxiety-inducing for many folks.”

The study concludes that “early legalization victories depended on Character judgments while the final nails were hammered into prohibition’s coffin with Plot-focused strategies revolving around politics and crime.”

“The shift happened entirely within the generalized portion of discourse, meaning that a non-compositional approach to frame classification would have missed it,” the paper states.

Hemmatian and his research team at Brown aren’t the only ones interested in exploring the intersection of drug policy and social media.

In fact, the Food and Drug Administration (FDA) recently announced that it plans to use Reddit and other “novel” data sources to gain a better understanding of public health issues surrounding use of CBD and other “emerging” marijuana derivatives like delta-8 THC.

The agency also wants to develop a system of finding “safety signals and usage patterns associated with emerging CDPs in real-time.” That includes delta-8 THC, a cannabinoid that the agency recently warned consumers about, as it has not yet evaluated its safety or efficacy.

Reddit users subscribed to the popular marijuana forum r/trees have previously helped researchers identify trends and patterns in cannabis consumption.

A peer-reviewed study published in the journal Drug and Alcohol Dependence in 2018 analyzed more than two million posts found on the site’s largest marijuana-related subreddit from 2010 to 2016. The research team made a series of discoveries, including a few that might seem obvious to regular consumers (e.g. dabbing is gaining in popularity, but users still largely favor smoking cannabis flower).

DEA Wants To Help Parents Decode The Emojis Young People Use To Discuss Marijuana And Other ‘Bomb Ass’ Drugs

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading
Advertisement

Marijuana News In Your Inbox

Support Marijuana Moment

Marijuana News In Your Inbox

Marijuana Moment